VKH
SCNI

Virtu KCG Holdings’s Scinai Immunotherapeutics SCNI Stock Holding History

Virtu KCG Holdings’s Portfolio SCNI Stock Details SCNI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-165
Closed -$82K – 3756
2015
Q2 		$82K Buy
+165
New +$77.7K ﹤0.01% 2971

Other funds holding SCNI

VIA
Vantage Investment Advisors State College, Pennsylvania $477M AUM 17.38% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Virtu KCG Holdings's SCNI Position: Q3 2015 in Review

Virtu KCG Holdings sold out of Scinai Immunotherapeutics (SCNI) in Q3 2015, closing a stake of 165 shares — an estimated $82K sold.

Virtu KCG Holdings first reported a position in SCNI in Q2 2015 and held it in 1 quarter. The position peaked at $82K in Q2 2015. 5 funds tracked by Wall St. Rank hold SCNI as of Q3 2015.

  • Virtu KCG Holdings reported no remaining Scinai Immunotherapeutics position as of Q3 2015 after selling out during the quarter.
  • Virtu KCG Holdings sold 165 Scinai Immunotherapeutics shares in Q3 2015, an estimated $82K.
  • Virtu KCG Holdings first reported a position in Scinai Immunotherapeutics in Q2 2015 and held it in 1 quarter.
  • Virtu KCG Holdings's Scinai Immunotherapeutics position peaked at $82K in Q2 2015.
  • 5 funds tracked by Wall St. Rank held Scinai Immunotherapeutics as of Q3 2015.

Based on Virtu KCG Holdings's 13F filing for Q3 2015, filed 13 Nov 2015.